Literature DB >> 18539244

Pulmonary hypertension caused by sarcoidosis.

Enrique Diaz-Guzman1, Carol Farver, Joseph Parambil, Daniel A Culver.   

Abstract

Pulmonary hypertension is an uncommon complication of sarcoidosis, but in severe pulmonary disease it occurs frequently. It is an important cause of cryptogenic dyspnea in sarcoidosis patients and can occur despite the absence of pulmonary fibrosis. The true prevalence is unknown. With the advent of specific therapies for pulmonary hypertension, there has been a resurgence of interest in the pathophysiology, diagnosis, and treatment of sarcoidosis-associated pulmonary hypertension. This article reviews the status of the current epidemiologic, pathophysiologic, and therapeutic knowledge regarding this entity.

Entities:  

Mesh:

Year:  2008        PMID: 18539244      PMCID: PMC2593121          DOI: 10.1016/j.ccm.2008.03.010

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  89 in total

1.  Successful treatment of sarcoidosis-associated pulmonary hypertension with bosentan.

Authors:  Raymond J Foley; Mark L Metersky
Journal:  Respiration       Date:  2005-11-15       Impact factor: 3.580

2.  Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure.

Authors:  K L Chan; P J Currie; J B Seward; D J Hagler; D D Mair; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1987-03       Impact factor: 24.094

3.  Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients.

Authors:  P J Currie; J B Seward; K L Chan; D A Fyfe; D J Hagler; D D Mair; G S Reeder; R A Nishimura; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1985-10       Impact factor: 24.094

4.  Pulmonary artery systolic pressures estimated by echocardiogram vs cardiac catheterization in patients awaiting lung transplantation.

Authors:  A Homma; A Anzueto; J I Peters; I Susanto; E Sako; M Zabalgoitia; C L Bryan; S M Levine
Journal:  J Heart Lung Transplant       Date:  2001-08       Impact factor: 10.247

5.  Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease.

Authors:  S M Palmer; L J Robinson; A Wang; J R Gossage; T Bashore; V F Tapson
Journal:  Chest       Date:  1998-01       Impact factor: 9.410

Review 6.  Pulmonary hypertension in patients with interstitial lung diseases.

Authors:  Jay H Ryu; Michael J Krowka; Patricia A Pellikka; Karen L Swanson; Michael D McGoon
Journal:  Mayo Clin Proc       Date:  2007-03       Impact factor: 7.616

7.  Endoluminal stenosis of proximal bronchi in sarcoidosis: bronchoscopy, function, and evolution.

Authors:  Arnaud Chambellan; Philippe Turbie; Hilario Nunes; Michel Brauner; Jean-Paul Battesti; Dominique Valeyre
Journal:  Chest       Date:  2005-02       Impact factor: 9.410

8.  Predicting mortality in patients with sarcoidosis awaiting lung transplantation.

Authors:  Andrew F Shorr; Darcy B Davies; Steven D Nathan
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

9.  Chronic cor pulmonale in pulmonary sarcoidosis.

Authors:  J P Battesti; R Georges; F Basset; G Saumon
Journal:  Thorax       Date:  1978-02       Impact factor: 9.139

10.  Intrapulmonary shunting in primary pulmonary hypertension: an observation in two patients treated with epoprostenol sodium.

Authors:  P F Castro; R C Bourge; D C McGiffin; R L Benza; P Fan; N B Pinkard; M D McGoon
Journal:  Chest       Date:  1998-07       Impact factor: 9.410

View more
  7 in total

Review 1.  A concise review of pulmonary sarcoidosis.

Authors:  Robert P Baughman; Daniel A Culver; Marc A Judson
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

Review 2.  Rare causes of pulmonary hypertension: spectrum of radiological findings and review of the literature.

Authors:  Alice Rossi; Maurizio Zompatori; Patrick Tchouante Tchouanhou; Michele Amadori; Massimiliano Palazzini; Elisa Conficoni; Nazzareno Galiè; Venerino Poletti; Giampaolo Gavelli
Journal:  Radiol Med       Date:  2013-11-15       Impact factor: 3.469

3.  The link between chronic thromboembolic pulmonary hypertension and sarcoidosis: association or visual masquerade?

Authors:  Rajive Tandon; Robert P Baughman; Janice Stanley; Ali A Khan
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

4.  Tattoo Koebnerization and Severe Pulmonary Hypertension.

Authors:  Matthew Patel; Karim Ladak
Journal:  Clin Med Res       Date:  2019-08-28

5.  Author Response: Pulmonary Vasodilators in Sarcoidosis-associated Pulmonary Hypertension.

Authors:  Matthew Patel; Karim Ladak
Journal:  Clin Med Res       Date:  2020-08

Review 6.  The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.

Authors:  Mao Wang; Alex Gauthier; LeeAnne Daley; Katelyn Dial; Jiaqi Wu; Joanna Woo; Mosi Lin; Charles Ashby; Lin L Mantell
Journal:  Antioxid Redox Signal       Date:  2019-07-11       Impact factor: 8.401

Review 7.  Sarcoidosis: Pitfalls and Challenging Mimickers.

Authors:  Naureen Narula; Michael Iannuzzi
Journal:  Front Med (Lausanne)       Date:  2021-01-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.